Skip to Main Content

Paper Details

Antiretroviral Therapy-Induced Bone Loss Is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-Naive Persons with Human Immunodeficiency Virus Infection: A Phase IIB Trial.
Clin Infect Dis
10
2020
Author NameAffiliation
Kirk A EasleyRollins School of Public Health, Emory University
  • 1 - 1

Datasets

Release 1.2